Literature DB >> 7598934

Leukocyte infiltration in allergic airway inflammation.

N W Lukacs1, R M Strieter, S L Kunkel.   

Abstract

The pathologic manifestation of an allergic airway response is a culmination of several coordinated events involving the participation of multiple mechanisms and cell types. The early release of mast cell-derived arachidonic acid metabolites, production of early-response cytokines, and increased expression of adhesion molecules and production of chemokines all lead to the recruitment of multiple cell types with the ability to participate in the allergic airway response. The coordinated use of animal models related to clinical observations will allow further elucidation of the mechanisms involved in the initiation, maintenance, and regulation of allergic airway inflammation leading to airway damage.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7598934     DOI: 10.1165/ajrcmb.13.1.7598934

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  10 in total

1.  Pulmonary overexpression of IL-9 induces Th2 cytokine expression, leading to immune pathology.

Authors:  Ulla-Angela Temann; Prabir Ray; Richard A Flavell
Journal:  J Clin Invest       Date:  2002-01       Impact factor: 14.808

2.  Compartmentalized transgene expression of granulocyte-macrophage colony-stimulating factor (GM-CSF) in mouse lung enhances allergic airways inflammation.

Authors:  X F Lei; Y Ohkawara; M R Stämpfli; J Gauldie; K Croitoru; M Jordana; Z Xing
Journal:  Clin Exp Immunol       Date:  1998-08       Impact factor: 4.330

3.  Role of stem cell factor and bone marrow-derived fibroblasts in airway remodeling.

Authors:  Vladislav A Dolgachev; Matthew R Ullenbruch; Nicholas W Lukacs; Sem H Phan
Journal:  Am J Pathol       Date:  2009-01-15       Impact factor: 4.307

4.  LTB4 is present in exudative pleural effusions and contributes actively to neutrophil recruitment in the inflamed pleural space.

Authors:  E Pace; M Profita; M Melis; A Bonanno; A Paternò; C H Mody; M Spatafora; M Ferraro; L Siena; A M Vignola; G Bonsignore; M Gjomarkaj
Journal:  Clin Exp Immunol       Date:  2004-03       Impact factor: 4.330

Review 5.  Transcriptional regulation of cytokine function in airway smooth muscle cells.

Authors:  Deborah Clarke; Gautam Damera; Maria B Sukkar; Omar Tliba
Journal:  Pulm Pharmacol Ther       Date:  2009-04-22       Impact factor: 3.410

6.  Lovastatin inhibits antigen-induced airway eosinophilia without affecting the production of inflammatory mediators in mice.

Authors:  Y Chiba; S Sato; M Misawa
Journal:  Inflamm Res       Date:  2009-05-06       Impact factor: 4.575

7.  The strength of the OVA-induced airway inflammation in rats is strain dependent.

Authors:  M N Hylkema; M O Hoekstra; M Luinge; W Timens
Journal:  Clin Exp Immunol       Date:  2002-09       Impact factor: 4.330

Review 8.  Systemic and cardiovascular effects of airway injury and inflammation: ultrafine particle exposure in humans.

Authors:  M W Frampton
Journal:  Environ Health Perspect       Date:  2001-08       Impact factor: 9.031

9.  Expression of interleukin 9 in the lungs of transgenic mice causes airway inflammation, mast cell hyperplasia, and bronchial hyperresponsiveness.

Authors:  U A Temann; G P Geba; J A Rankin; R A Flavell
Journal:  J Exp Med       Date:  1998-10-05       Impact factor: 14.307

10.  Ma Xing Shi Gan Decoction Attenuates PM2.5 Induced Lung Injury via Inhibiting HMGB1/TLR4/NFκB Signal Pathway in Rat.

Authors:  Yu-Xiang Fei; Bo Zhao; Qi-Yang Yin; Yan-Ying Qiu; Guang-Hui Ren; Bo-Wen Wang; Ye-Fang Wang; Wei-Rong Fang; Yun-Man Li
Journal:  Front Pharmacol       Date:  2019-11-14       Impact factor: 5.810

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.